文献速递肾小球疾病遗传性与小管间质肾病

丙氨酰-tRNA合成酶1与常染色体显性多囊肾病囊肿生长

Alanyl-Transfer RNA Synthetase 1 and Cyst Growth in Autosomal Dominant Polycystic Kidney Disease.
PubMed 文献 · J Am Soc Nephrol · 2026-06-26

该研究在Pkd1突变小鼠中发现AARS1表达升高,通过促进STAT3和NF-κB p65的赖氨酸乳酰化增强其磷酸化与转录活性,并抑制Atg5和Dusp4转录以损害自噬、激活多囊肾病信号通路;遗传缺失Aars1或使用抑制剂β-丙氨酸可延缓囊肿进展并保护肾功能。

要点

  • AARS1在ADPKD中上调并促进囊肿生长,遗传缺失可延缓囊肿进展并保护肾功能。
  • AARS1通过乳酰化STAT3 K140和p65 K310增强其磷酸化、相互作用和转录活性。
  • AARS1抑制剂β-丙氨酸可减缓Pkd1突变小鼠的囊肿进展。

核心结论

  • AARS1是连接乳酸驱动的赖氨酸乳酰化与转录、表观遗传及信号通路的核心代谢传感器,驱动ADPKD进展。

研究设计与样本

  • 研究构建了Pkd1fl/fl:Aars1fl/fl:Ksp-Cre双条件敲除小鼠,并在两种ADPKD小鼠模型中评估AARS1抑制剂β-丙氨酸的效果。
  • 采用免疫共沉淀和CUT&Tag分析鉴定AARS1的新底物及下游靶基因。

主要发现

  • AARS1在Pkd1突变肾上皮细胞和肾脏中升高,遗传缺失Aars1显著延缓囊肿生长、保护肾功能并减少肾脏乳酰化。
  • AARS1促进STAT3 K140和p65 K310的乳酰化依赖性激活,放大促增殖和促炎转录程序。
  • AARS1结合启动子区域并介导组蛋白H3K14乳酰化,抑制Atg5转录损害自噬,抑制Dusp4转录维持CREB和Rb磷酸化。
  • IL-6和TNF-α通过STAT3和NF-κB依赖性正反馈环路增强AARS1表达。
  • β-丙氨酸抑制AARS1可显著减缓Pkd1突变小鼠模型的囊肿进展。

临床怎么用

  • 靶向AARS1(如β-丙氨酸)可能成为延缓ADPKD囊肿进展的潜在治疗策略。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

KEY POINTS: Alanyl-transfer RNA synthetase 1 (AARS1) was upregulated and promoted cyst growth in autosomal dominant polycystic kidney disease. AARS1 promoted lysine lactylation of signal transducer and activator of transcription 3 (K140) and NF-κB p65 (K310), enhancing their phosphorylation, interaction, and transcriptional activity. AARS1 transcriptionally repressed its novel targets, Atg5 and Dusp4, to impair autophagy but activate polycystic kidney disease signaling pathways. BACKGROUND: Autosomal dominant polycystic kidney disease (ADPKD) is the most common inherited kidney disorder, characterized by metabolic reprogramming with enhanced glycolysis and lactate accumulation. However, the enzyme that senses lactate and uses it as a substrate for protein lactylation in ADPKD remains unknown. Alanyl-transfer RNA synthetase 1 (AARS1) is a lactate-responsive enzyme with lactyltransferase activity, while its role and mechanisms in ADPKD have not been defined. METHODS: To investigate the role of AARS1, we generated Pkd1 and Aars1 double conditional knockout Pkd1fl/fl:Aars1fl/fl:Ksp-Cre mice and evaluated the effect of AARS1 inhibitor β -alanine in two ADPKD mouse models. Coimmunoprecipitation and Cleavage Under Targets and Tagmentation analyses were performed to identify novel AARS1 substrates and downstream target genes involved in cystogenesis. RESULTS: AARS1 was elevated in Pkd1 mutant renal epithelial cells and kidneys, and genetic deletion of Aars1 significantly delayed cyst growth, preserved kidney function, and reduced renal lactylation in Pkd1 mutant mice. Mechanistically, AARS1 promoted lactylation-dependent activation of signal transducer and activator of transcription 3 (STAT3) and NF-κB (p65), specifically at STAT3 K140 and p65 K310, thereby amplifying pro-proliferative and proinflammatory transcriptional programs. AARS1 also associated with promoter regions and mediated histone H3 lysine 14 lactylation, thereby repressing the transcription of Atg5 to impair autophagy and suppressing the transcription of Dusp4 to sustain phosphorylation of cAMP response element-binding protein and retinoblastoma protein. Cytokine signaling through IL-6 and TNF- α further reinforced AARS1 expression through STAT3- and NF-κB-dependent feed-forward loops. Importantly, inhibition of AARS1 with β -alanine markedly slowed cyst progression in Pkd1 mutant mouse models. CONCLUSIONS: Our study identified AARS1 as a central metabolic sensor linking lactate-driven lysine lactylation to transcriptional, epigenetic, and signaling pathways that drive ADPKD progression.

来源:J Am Soc Nephrol,查看原文。版权归原作者所有。

引用

  1. Tian L, Wang Y, Li LX, et al. Alanyl-Transfer RNA Synthetase 1 and Cyst Growth in Autosomal Dominant Polycystic Kidney Disease. J Am Soc Nephrol. 2026. PMID: 42329029. doi:10.1681/ASN.0000001169

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。